Image of The safety of bortezomib for the treatment of multiple myeloma

LITERATURE

The safety of bortezomib for the treatment of multiple myeloma


There is now 16 years’ worth of established results of various trials demonstrating the bortezomib efficiency in the treatment of multiple myeloma. Over this time, the introduction of bortezomib has been a major break through in the treatment of
multiple myeloma. Bortezomib can be administered in the outpatient setting with manageable toxicities.


Availability

Fonkozomib-003Available

Detail Information

Series Title
-
Call Number
-
Publisher : .,
Collation
-
Language
English
ISBN/ISSN
-
Classification
NONE
Content Type
-
Media Type
-
Carrier Type
-
Edition
-
Subject(s)
Specific Detail Info
Expert Opinion on Drug Safety
Statement of Responsibility

Other version/related

No other version available


File Attachment



Information


RECORD DETAIL


Back To Previous